SCHEMBL13330734

SCHEMBL13330734

CCc1cc(NS(C)(=O)=O)ccc1-c1noc(-c2cn3cc(C#N)cc(Cl)c3n2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 6/20 0.37
NR3C1 P04150 4/20 0.37
NR3C2 P08235 4/20 0.37
AR P10275 3/20 0.37
DPP4 P27487 5/20 0.33
DPP7 Q9UHL4 5/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
TDP2 O95551 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
CYP17A1 P05093 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
MAPK1 P28482 1/20 0.31
S1PR1 P21453 1/20 0.31
SMARCA2 P51531 1/20 0.31
EPHX2 P34913 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3339689 0.91 DPP4 (0.40) PGRNR3C1NR3C2ARDPP4
SCHEMBL3342927 0.84 DPP4 (0.39) PGRNR3C1NR3C2ARDPP4
SCHEMBL3341183 0.79 DPP4 (0.41) DPP4DPP7CYP17A1GAAHPGD
SCHEMBL3339938 0.76 DPP4 (0.45) DPP4DPP7GAAHPGDMAPK1
SCHEMBL3339591 0.75 NPC1 (0.45) PGRDPP4DPP7EPHX2NR1H4
SCHEMBL3340510 0.75 NPC1 (0.43) DPP4DPP7CYP17A1EPHX2NR1H4
SCHEMBL3339344 0.73 DPP4 (0.41) DPP4DPP7CYP17A1GAAHPGD
SCHEMBL3340793 0.70 NPC1 (0.50) MAPK1S1PR1
SCHEMBL3339352 0.70 DPP4 (0.38) DPP4DPP7S1PR1
SCHEMBL13330765 0.69 NPC1 (0.40) DPP4DPP7CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010065760-A1 IMIDAZO [1,2A] PYRIDINE DERIVATIVES, THEIR USE AS S1P1 AGONISTS AND METHODS FOR THEIR PRODUCTION EXELIXIS, INC. (US) 2010-06-10 WO disclosed